In 2023, India's import of cortisone, hydrocortisone, prednisone, and prednisolone stood at approximately USD 45.7 million. Forecasted data from 2024 to 2028 indicates a steady growth with year-on-year increments averaging around 2%. Over the five-year forecast period, the compound annual growth rate (CAGR) is anticipated to be roughly 2.04%. This suggests a consistent rise in demand for these pharmaceutical products in India.

Future trends to watch for include:

Potential shifts in global pharmaceutical supply chains that could impact import patterns.
Regulatory changes in India that might affect the demand for imported corticosteroids.
Developments in local production capacities that could influence import volumes.